文献速递胸部儿科影像MR

囊性纤维化患者在CFTR调节剂治疗前及治疗期间的肺功能:三维超短回波时间MRI研究

Lung Function in Patients with Cystic Fibrosis before and during CFTR-Modulator Therapy Using 3D Ultrashort Echo Time MRI.
PubMed 文献 · Radiology · 2023-01-01

这项前瞻性可行性研究纳入16例囊性纤维化患者,其中8例在基线后接受elexacaftor/tezacaftor/ivacaftor治疗,8例治疗不变作为对照组,比较三维超短回波时间MRI功能肺参数与常规肺功能参数。结果显示MRI通气不均匀性与肺清除指数相关,治疗组随访时通气不均匀性和通气缺损百分比降低,MRI可提供区域信息补充全局参数。

要点

  • 3D UTE MRI通气不均匀性与肺清除指数在基线和随访时均相关。
  • 治疗组随访时MRI通气不均匀性和通气缺损百分比较基线降低。
  • MRI功能参数可提供区域信息,补充LCI等全局参数。

核心结论

  • 无对比剂3D UTE肺MRI的通气不均匀性和通气缺损百分比功能参数可用于评估囊性纤维化患者随时间变化的肺功能,并能对LCI等既定全局参数增加区域信息。

研究设计与样本

  • 前瞻性可行性研究,16例囊性纤维化患者,其中8例在基线后接受elexacaftor/tezacaftor/ivacaftor治疗,8例治疗不变作为对照组,基线(2018年4月至2019年6月)和随访(2021年4月至7月)行屏气3D UTE序列肺MRI,以体描计和肺清除指数评估肺功能。

关键影像表现/征象

  • MRI通气不均匀性与LCI在基线(r=0.92,P<.001)和随访(r=0.81,P=.002)均相关。
  • 在全部参与者中,第1秒用力呼气容积与MRI通气不均匀性的相关性在基线良好(r=-0.61,P=.01),随访时差(r=-0.06,P=.82)。

诊断标准与关键数值

  • MRI通气不均匀性与LCI在基线r=0.92(P<.001)、随访r=0.81(P=.002)。
  • 治疗组平均MRI通气不均匀性基线0.74±0.15,随访0.64±0.11(P=.02)。
  • 治疗组平均通气缺损百分比基线14.1%±7.4,随访8.5%±3.3(P=.02)。
  • 对照组平均LCI基线9.3 turnovers±4.1,随访11.5 turnovers±7.4(P=.34)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The triple combination of the cystic fibrosis transmembrane regulator (CFTR) modulators elexacaftor, tezacaftor, and ivacaftor (hereafter, elexacaftor/tezacaftor/ivacaftor) has a positive effect on lung function in patients with cystic fibrosis (CF). Purpose To compare three-dimensional (3D) ultrashort echo time (UTE) MRI functional lung data to common functional lung parameters in assessing lung function in patients with CF undergoing elexacaftor/tezacaftor/ivacaftor therapy. Materials and Methods In this prospective feasibility study, 16 participants with CF consented to undergo pulmonary MRI with a breath-hold 3D UTE sequence at baseline (April 2018-June 2019) and follow-up (April-July 2021). Eight participants received elexacaftor/tezacaftor/ivacaftor after baseline, and eight participants with unchanged treatment served as the control group. Lung function was assessed with body plethysmography and lung clearance index (LCI). Image-based functional lung parameters, such as ventilation inhomogeneity and ventilation defect percentage (VDP), were calculated from signal intensity change between MRI scans at inspiration and expiration. Metrics at baseline and follow-up were compared within groups (permutation test), correlation was tested (Spearman rank correlation), and 95% CIs were calculated (bootstrapping technique). Results MRI ventilation inhomogeneity correlated with LCI at baseline (r = 0.92, P < .001) and follow-up (r = 0.81, P = .002). Mean MRI ventilation inhomogeneity (baseline, 0.74 ± 0.15 [SD]; follow-up, 0.64 ± 0.11; P = .02) and mean VDP (baseline, 14.1% ± 7.4; follow-up, 8.5% ± 3.3; P = .02) decreased from baseline to follow-up in the treatment group. Lung function was stable over time (mean LCI: 9.3 turnovers ± 4.1 at baseline vs 11.5 turnovers ± 7.4 at follow-up; P = .34) in the control group. In all participants, correlation of forced expiratory volume in 1 second with MRI ventilation inhomogeneity was good at baseline (r = -0.61, P = .01) but poor during follow-up (r = -0.06, P = .82). Conclusion Noncontrast 3D UTE lung MRI functional parameters of ventilation inhomogeneity and VDP can be used to assess lung function over time in patients with CF and can add regional information to established global parameters, such as LCI. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Iwasawa in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Heidenreich JF, Kuhl PJ, Grunz JP, et al. Lung Function in Patients with Cystic Fibrosis before and during CFTR-Modulator Therapy Using 3D Ultrashort Echo Time MRI. Radiology. 2023. PMID: 37404154. doi:10.1148/radiol.230084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。